99 related articles for article (PubMed ID: 28111258)
1. Mutations and interactions in human ERα and bZIP proteins: An in silico approach for cell signaling in breast oncology.
Banerjee A; Ray S
Gene; 2017 Apr; 610():90-102. PubMed ID: 28111258
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the
Chitrala KN; Nagarkatti M; Nagarkatti P; Yeguvapalli S
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216622
[TBL] [Abstract][Full Text] [Related]
3. [XBP-1 interacts with estrogen receptor alpha (ERalpha)].
Ding LH; Ye QN; Yan JH; Zhu JH; Lü QJ; Wang ZH; Huang CF
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):332-6. PubMed ID: 15971600
[TBL] [Abstract][Full Text] [Related]
4. Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis.
Zeng H; Xu W
Genes Dev; 2015 Oct; 29(20):2153-67. PubMed ID: 26494790
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.
Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z
J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358
[TBL] [Abstract][Full Text] [Related]
6. Investigation of binding mechanism and downregulation of elacestrant for wild and L536S mutant estrogen receptor-α through molecular dynamics simulation and binding free energy analysis.
Chinnasamy K; Saravanan M; Poomani K
J Comput Chem; 2020 Jan; 41(2):97-109. PubMed ID: 31602686
[TBL] [Abstract][Full Text] [Related]
7. Mutational Impact on the Interaction Between Human IL27 and gp130: In silico Approach for Defending HIV Infection.
Banerjee A; Dasgupta R; Ray S
Curr HIV Res; 2017 Nov; 15(5):327-335. PubMed ID: 28820066
[TBL] [Abstract][Full Text] [Related]
8. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells.
Kanaujiya JK; Lochab S; Kapoor I; Pal P; Datta D; Bhatt ML; Sanyal S; Behre G; Trivedi AK
Proteomics; 2013 Jul; 13(14):2100-12. PubMed ID: 23576398
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha.
Zhou D; Ye JJ; Li Y; Lui K; Chen S
Nucleic Acids Res; 2006; 34(20):5974-86. PubMed ID: 17068076
[TBL] [Abstract][Full Text] [Related]
11. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
[TBL] [Abstract][Full Text] [Related]
12. Ligand-independent activation of estrogen receptor alpha by XBP-1.
Ding L; Yan J; Zhu J; Zhong H; Lu Q; Wang Z; Huang C; Ye Q
Nucleic Acids Res; 2003 Sep; 31(18):5266-74. PubMed ID: 12954762
[TBL] [Abstract][Full Text] [Related]
13. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
14. ERRF is essential for Estrogen-Estrogen Receptor alpha signaling pathway in ER positive breast cancer cells.
Luo A; Zhang X
Biochem Biophys Res Commun; 2016 May; 474(2):400-405. PubMed ID: 27125460
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.
Nichols M; Cheng P; Liu Y; Kanterewicz B; Hershberger PA; McCarty KS
Breast Cancer Res Treat; 2010 Apr; 120(3):761-8. PubMed ID: 19526339
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation.
Fanning SW; Mayne CG; Dharmarajan V; Carlson KE; Martin TA; Novick SJ; Toy W; Green B; Panchamukhi S; Katzenellenbogen BS; Tajkhorshid E; Griffin PR; Shen Y; Chandarlapaty S; Katzenellenbogen JA; Greene GL
Elife; 2016 Feb; 5():. PubMed ID: 26836308
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between the ligand- and DNA-binding domains of estrogen receptor.
Huang W; Greene GL; Ravikumar KM; Yang S
Proteins; 2013 Nov; 81(11):1900-9. PubMed ID: 23737157
[TBL] [Abstract][Full Text] [Related]
18. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
[TBL] [Abstract][Full Text] [Related]
19. The nuclear receptor coactivator PGC-1alpha exhibits modes of interaction with the estrogen receptor distinct from those of SRC-1.
Bourdoncle A; Labesse G; Margueron R; Castet A; Cavaillès V; Royer CA
J Mol Biol; 2005 Apr; 347(5):921-34. PubMed ID: 15784253
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer.
Anbalagan M; Rowan BG
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():264-72. PubMed ID: 25597633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
